Literature DB >> 33097599

Bi-directional association between epilepsy and dementia: The Framingham Heart Study.

Maria Stefanidou1, Alexa S Beiser2, Jayandra Jung Himali2, Teng J Peng2, Orrin Devinsky2, Sudha Seshadri2, Daniel Friedman2.   

Abstract

OBJECTIVE: To assess the risk of incident epilepsy among participants with prevalent dementia and the risk of incident dementia among participants with prevalent epilepsy in the Framingham Heart Study (FHS).
METHODS: We analyzed prospectively collected data in the Original and Offspring FHS cohorts. To determine the risk of developing epilepsy among participants with dementia and the risk of developing dementia among participants with epilepsy, we used separate, nested, case-control designs and matched each case to 3 age-, sex- and FHS cohort-matched controls. We used Cox proportional hazards regression analysis, adjusting for sex and age. In secondary analysis, we investigated the role of education level and APOE ε4 allele status in modifying the association between epilepsy and dementia.
RESULTS: A total of 4,906 participants had information on epilepsy and dementia and dementia follow-up after age 65. Among 660 participants with dementia and 1,980 dementia-free controls, there were 58 incident epilepsy cases during follow-up. Analysis comparing epilepsy risk among dementia cases vs controls yielded a hazard ratio (HR) of 1.82 (95% confidence interval 1.05-3.16, p = 0.034). Among 43 participants with epilepsy and 129 epilepsy-free controls, there were 51 incident dementia cases. Analysis comparing dementia risk among epilepsy cases vs controls yielded a HR of 1.99 (1.11-3.57, p = 0.021). In this group, among participants with any post-high school education, prevalent epilepsy was associated with a nearly 5-fold risk for developing dementia (HR 4.67 [1.82-12.01], p = 0.001) compared to controls of the same educational attainment.
CONCLUSIONS: There is a bi-directional association between epilepsy and dementia. with either condition carrying a nearly 2-fold risk of developing the other when compared to controls.
© 2020 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33097599      PMCID: PMC7836659          DOI: 10.1212/WNL.0000000000011077

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  49 in total

Review 1.  Seizures and epilepsy in Alzheimer's disease.

Authors:  Daniel Friedman; Lawrence S Honig; Nikolaos Scarmeas
Journal:  CNS Neurosci Ther       Date:  2011-06-07       Impact factor: 5.243

2.  Epilepsy and Alzheimer's Disease: Ubiquitous Entities Subject to the Same Cosmic Forces but on Different Astral Planes.

Authors:  Cynthia L Harden
Journal:  Epilepsy Curr       Date:  2018 Sep-Oct       Impact factor: 7.500

3.  No Evidence of a Causal Role of Antiepileptic Drug Treatment with Regard to the Development of Dementia.

Authors:  Christoph Helmstaedter; Ettore Beghi; Christian E Elger; Reetta Kälviäinen; Kristina Malmgren; Theodor W May; Emilio Perucca; Eugen Trinka; Juri-Alexander Witt
Journal:  J Am Geriatr Soc       Date:  2018-08-09       Impact factor: 5.562

4.  Relative Incidence of Seizures and Myoclonus in Alzheimer's Disease, Dementia with Lewy Bodies, and Frontotemporal Dementia.

Authors:  Alexander J Beagle; Sonja M Darwish; Kamalini G Ranasinghe; Alice L La; Elissaios Karageorgiou; Keith A Vossel
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

5.  Incidence of new-onset seizures in mild to moderate Alzheimer disease.

Authors:  Michael C Irizarry; Shelia Jin; Feng He; Jennifer A Emond; Rema Raman; Ronald G Thomas; Mary Sano; Joseph F Quinn; Pierre N Tariot; Douglas R Galasko; Lianna S Ishihara; John G Weil; Paul S Aisen
Journal:  Arch Neurol       Date:  2012-03

6.  Differential cognitive effects of carbamazepine and gabapentin.

Authors:  K J Meador; D W Loring; P G Ray; A M Murro; D W King; M E Nichols; E M Deer; W T Goff
Journal:  Epilepsia       Date:  1999-09       Impact factor: 5.864

Review 7.  The association between dementia and epilepsy: A systematic review and meta-analysis.

Authors:  Ann Subota; Tram Pham; Nathalie Jetté; Khara Sauro; Diane Lorenzetti; Jayna Holroyd-Leduc
Journal:  Epilepsia       Date:  2017-04-11       Impact factor: 5.864

8.  Antiepileptic drugs are not independently associated with cognitive dysfunction.

Authors:  Emma Foster; Charles B Malpas; Karena Ye; Benjamin Johnstone; Patrick W Carney; Dennis Velakoulis; Terence J O'Brien; Patrick Kwan
Journal:  Neurology       Date:  2020-02-03       Impact factor: 9.910

9.  An investigation of coronary heart disease in families. The Framingham offspring study.

Authors:  W B Kannel; M Feinleib; P M McNamara; R J Garrison; W P Castelli
Journal:  Am J Epidemiol       Date:  1979-09       Impact factor: 4.897

10.  Neurologic signs in Alzheimer's disease. Results of a prospective clinical and neuropathologic study.

Authors:  H Förstl; A Burns; R Levy; N Cairns; P Luthert; P Lantos
Journal:  Arch Neurol       Date:  1992-10
View more
  10 in total

Review 1.  Mechanisms Involved in Epileptogenesis in Alzheimer's Disease and Their Therapeutic Implications.

Authors:  Miren Altuna; Gonzalo Olmedo-Saura; María Carmona-Iragui; Juan Fortea
Journal:  Int J Mol Sci       Date:  2022-04-13       Impact factor: 6.208

2.  Association of cognitive enhancers and incident seizure risk in dementia: a population-based study.

Authors:  Junghee Ha; Nak-Hoon Son; Young Ho Park; Eun Lee; Eosu Kim; Woo Jung Kim
Journal:  BMC Geriatr       Date:  2022-06-03       Impact factor: 4.070

3.  Decreased synapse-associated proteins are associated with the onset of epileptic memory impairment in endothelial CDK5-deficient mice.

Authors:  Zheng-Mao Li; Xiu-Xiu Liu; Chen Li; Zhao-Cong Wei; Yi Shi; Heng-Yi Song; Xiang Chen; Yu Zhang; Jia-Wei Li; Rui-Fang Zhu; Ben-Hui Hu; Wei-Feng Ye; Da Huo; Guo-Jun Jiang; Takuya Sasaki; Li Zhang; Feng Han; Ying-Mei Lu
Journal:  MedComm (2020)       Date:  2022-06-20

4.  Contribution of vascular risk factors to the relationship between ADHD symptoms and cognition in adults and seniors.

Authors:  Brandy L Callahan; André Plamondon; Sascha Gill; Zahinoor Ismail
Journal:  Sci Rep       Date:  2021-12-20       Impact factor: 4.379

5.  Association of a wide range of chronic diseases and apolipoprotein E4 genotype with subsequent risk of dementia in community-dwelling adults: A retrospective cohort study.

Authors:  Xianwen Shang; Zhuoting Zhu; Xueli Zhang; Yu Huang; Xiayin Zhang; Jiahao Liu; Wei Wang; Shulin Tang; Honghua Yu; Zongyuan Ge; Xiaohong Yang; Mingguang He
Journal:  EClinicalMedicine       Date:  2022-03-13

Review 6.  Sleep: The Tip of the Iceberg in the Bidirectional Link Between Alzheimer's Disease and Epilepsy.

Authors:  Anna B Szabo; Benjamin Cretin; Fleur Gérard; Jonathan Curot; Emmanuel J Barbeau; Jérémie Pariente; Lionel Dahan; Luc Valton
Journal:  Front Neurol       Date:  2022-04-11       Impact factor: 4.086

Review 7.  The clinical correlation between Alzheimer's disease and epilepsy.

Authors:  Dandan Zhang; Siyuan Chen; Shoucheng Xu; Jing Wu; Yuansu Zhuang; Wei Cao; Xiaopeng Chen; Xuezhong Li
Journal:  Front Neurol       Date:  2022-07-22       Impact factor: 4.086

8.  Mortality in Patients With Late-Onset Epilepsy: Results From the Atherosclerosis Risk in Communities Study.

Authors:  Emily L Johnson; Gregory L Krauss; Anna Kucharska-Newton; Alice D Lam; Rani Sarkis; Rebecca F Gottesman
Journal:  Neurology       Date:  2021-07-19       Impact factor: 11.800

9.  The role of mTORC1 activation in seizure-induced exacerbation of Alzheimer's disease.

Authors:  Sarah Gourmaud; David A Stewart; David J Irwin; Nicholas Roberts; Aaron J Barbour; Grace Eberwine; William T O'Brien; Robert Vassar; Delia M Talos; Frances E Jensen
Journal:  Brain       Date:  2022-03-29       Impact factor: 15.255

Review 10.  Application of single cell genomics to focal epilepsies: A call to action.

Authors:  Sattar Khoshkhoo; Dennis Lal; Christopher A Walsh
Journal:  Brain Pathol       Date:  2021-07       Impact factor: 6.508

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.